A Novel CDC42 Variant with Impaired Thymopoiesis, IL-7R Signaling, PAK1 Binding, and TCR Repertoire Diversity.

MLA

Assing, Kristian, et al. “A Novel CDC42 Variant with Impaired Thymopoiesis, IL-7R Signaling, PAK1 Binding, and TCR Repertoire Diversity.” Journal of Clinical Immunology, vol. 43, no. 8, Nov. 2023, pp. 1927–40. EBSCOhost, https://doi.org/10.1007/s10875-023-01561-0.

APA

Assing, K., Jørgensen, S. E., Sandgaard, K. S., De Keukeleere, K., B-Hansen, M., Petersen, M. S., Hartling, U. B., Vaal, T. M. K., Nielsen, C., Jakobsen, M. A., Watt, E., Adams, S., Hao, Q., Fagerberg, C., & Mogensen, T. H. (2023). A Novel CDC42 Variant with Impaired Thymopoiesis, IL-7R Signaling, PAK1 Binding, and TCR Repertoire Diversity. Journal of Clinical Immunology, 43(8), 1927–1940. https://doi.org/10.1007/s10875-023-01561-0

Chicago

Assing, Kristian, Sofie E Jørgensen, Katrine S Sandgaard, Kerstin De Keukeleere, Marie B-Hansen, Mikkel S Petersen, Ulla B Hartling, et al. 2023. “A Novel CDC42 Variant with Impaired Thymopoiesis, IL-7R Signaling, PAK1 Binding, and TCR Repertoire Diversity.” Journal of Clinical Immunology 43 (8): 1927–40. doi:10.1007/s10875-023-01561-0.